These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic. Bielaszewska M; Janda J; Blahová K; Feber J; Potuzník V; Soucková A Clin Nephrol; 1996 Jul; 46(1):42-4. PubMed ID: 8832150 [TBL] [Abstract][Full Text] [Related]
11. A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli O157:H7. Lissner R; Schmidit H; Karch H Infection; 1996; 24(5):378-83. PubMed ID: 8923050 [TBL] [Abstract][Full Text] [Related]
12. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli. Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728 [TBL] [Abstract][Full Text] [Related]
13. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Bitzan M; Ludwig K; Klemt M; König H; Büren J; Müller-Wiefel DE Epidemiol Infect; 1993 Apr; 110(2):183-96. PubMed ID: 8472763 [TBL] [Abstract][Full Text] [Related]
14. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. Ashkenazi S; Cleary TG J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433 [TBL] [Abstract][Full Text] [Related]
15. A biotyping scheme for Shiga-like (Vero) toxin-producing Escherichia coli O157 and a list of serological cross-reactions between O157 and other gram-negative bacteria. Aleksić S; Karch H; Bockemühl J Zentralbl Bakteriol; 1992 Jan; 276(2):221-30. PubMed ID: 1559010 [TBL] [Abstract][Full Text] [Related]
16. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery. Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317 [TBL] [Abstract][Full Text] [Related]
18. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae. Sreerohini S; Balakrishna K; Parida M APMIS; 2019 Oct; 127(10):671-680. PubMed ID: 31344276 [TBL] [Abstract][Full Text] [Related]
19. Effects of human intravenous immune globulin on diarrhea caused by Shiga-like toxin I and Shiga-like toxin II in infant rabbits. Havens PL; Dunne WM; Burd EM Microbiol Immunol; 1992; 36(10):1077-85. PubMed ID: 1479962 [TBL] [Abstract][Full Text] [Related]
20. Evidence of infection with organisms producing Shiga-like toxins in household contacts of children with the hemolytic uremic syndrome. Lopez EL; Diaz M; Devoto S; Grinstein S; Woloj M; Murray BE; Rubeglio E; Mendilaharzu F; Turco M; Vasquez M Pediatr Infect Dis J; 1991 Jan; 10(1):20-4. PubMed ID: 2003052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]